안트로젠 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 이성구, was filed 10 Jul 2026.
Who traded when
BuySaleSince the insiders bought
- -64.3%Entry ₩37,400 · Close 30 Oct 2026 ₩13,360
- -15.8%Entry ₩16,750 · Close at T+365 ₩14,110
- -3.9%Entry ₩15,610 · Close at T+365 ₩15,000
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2023FY ended December 2023 · cache
- 11,400 sharesKRXDART:20260710000350Canonical exit: 8 Oct 2026 (T+90)
- 6,000 sharesShareKRXDART:20260709000432Canonical exit: 7 Oct 2026 (T+90)
- 24,684 sharesKRXDART:20260421000193Canonical exit: 19 Jul 2026 (T+90)
- 108,158 sharesKRXDART:20251224000420Canonical exit: 2 May 2021 (T+90)
- 6,169 sharesKRXDART:20251224000431
- 78,102 sharesKRXDART:20251224000428Canonical exit: 24 May 2022 (T+90)
- 2,350 shares@ ₩15,760.00100.0% of flowShareKRXDART:20230908000281Canonical exit: 3 Dec 2023 (T+90)
- ●Executives0DART
- 7,000 shares@ ₩14,303.0092.2% of flowShareKRXDART:20230802000139Canonical exit: 26 Oct 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- 1,000 shares@ ₩8,000.007.8% of flowShareKRXDART:20220812000004Canonical exit: 7 Nov 2022 (T+90)
- 6,169 sharesKRXDART:20220331001370
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 108,158 sharesKRXDART:20210628000290Canonical exit: 26 Sept 2021 (T+90)
25 of 29 declarations
About 안트로젠
안트로젠, a South Korean healthcare company valued at KRW 143.6 billion, has 29 filings from 10 filers, published from May 20, 2021 to July 10, 2026. The flow leans to buying: 12 purchases against 2 sales, so 86% of open-market trades are purchases, plus 15 filings of another nature. Only three purchases carry an amount, EUR 102,977 in total, median EUR 25,999.
The largest is 김인옥's: EUR 70,986 on July 28, 2023, after EUR 5,992 on August 9, 2022. A purchase of EUR 25,999, filed by 류홍기, dates from September 4, 2023. 이성구, a major holder (대량보유자), filed 11 times, including 7 purchases and 2 sales. 김미형, a representative director (대표이사), has 2 filings including 1 purchase. The company itself, 안트로젠, appears on 5 filings with no purchase or sale.
Read moreShow less
On July 9 and 10, 2026, two insiders bought within one window. The last twelve months hold 6 filings: 5 purchases and 1 sale. Recorded trades run from February 1, 2021 to April 20, 2026, and filings appear a median of 4 days after the trade.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
